ERBB2 and prostate cancer: Correlation between oncogenes (HER2/neu and BCL2), tumor suppressor gene (p53), tumor proliferation rate (proliferating cell nuclear antigen), and specimen pathological variables in prostatic cancer patients, operated in Hospital Sírio Libanês, São Paulo